WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) again urged the U.S. EPA to abandon its ethylene oxide (EtO) risk assessment value for one that is more feasible, based on the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither…
WASHINGTON and SAN DIEGO – February 10, 2020 – The Advanced Medical Technology Association® (AdvaMed®) and Biocom, the association representing the California life science industry, today announced a joint partnership to…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the signing into law of the United States-Mexico-Canada Agreement (USMCA) by…
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the emergence of the coronavirus:
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on President Trump’s signing of legislation to repeal the medical device excise…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
Contact: Mark [email protected] WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax: “On behalf…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device…